BRX 0.25 (Rexulti 0.25 mg)
Generic Name: brexpiprazole
Pill with imprint BRX 0.25 is Brown, Round and has been identified as Rexulti 0.25 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd. and Lundbeck.
Rexulti is used in the treatment of major depressive disorder; depression; schizophrenia and belongs to the drug class atypical antipsychotics. Rexulti 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BRX 0.25
Rexulti
- Generic Name:
- brexpiprazole
- Imprint:
- BRX 0.25
- Strength:
- 0.25 mg
- Color:
- Brown
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Atypical antipsychotics
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Otsuka Pharmaceutical Co., Ltd. and Lundbeck
- National Drug Code (NDC):
- 59148-0035
More about Rexulti (brexpiprazole)
- Rexulti Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 134 Reviews – Add your own review/rating
- Drug class: atypical antipsychotics
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
